LEGN · US market
LEGEND BIOTECH ADR REP
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$3.57bnFinancials dated 31 December 2025Price dated 1 October 2026
Core valuation
* P/E uses the latest reported full year ended 31 December 2025 because neither a trailing four-quarter value nor a latest-quarter value is available.
* P/S uses the latest reported full year ended 31 December 2025 because neither a trailing four-quarter value nor a latest-quarter value is available.
Calculation inputs
- Trailing earnings
- Unavailable
- Latest-quarter run-rate earnings
- Unavailable
- Latest fiscal-year earnings
- -US$296.80m
- Trailing revenue
- Unavailable
- Latest-quarter run-rate revenue
- Unavailable
- Latest fiscal-year revenue
- US$1.03bn
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- MEDI · Harbor Health Care ETF5.13% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- GNOM · Global X Genomics & Biotechnology ETF3.93% weight · Holdings dated 31 May 2026
- FMED · Fidelity Disruptive Medicine ETF2.29% weight · Holdings dated 31 May 2026
- FSSMX · Fidelity Stock Selector Mid Cap Fund0.30% weight · Holdings dated 31 May 2026
- AFGGX · Yorktown Growth Fund Class A0.28% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- FSSLX · Fidelity Series Small Cap Core Fund0.27% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- IBB · iShares Biotechnology ETF0.23% weight · Holdings dated 19 August 2026
- FOTHX · Fidelity Advisor OTC Fund Class I0.22% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- FOKFX · Fidelity OTC K6 Portfolio0.22% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- FDESX · Fidelity Advisor Diversified Stock Fund Class O0.18% weight · Holdings dated 30 June 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 31 December 2025. Informational research, not investment advice.